http://www.world-wire.com/news/1005030001.html
Damn nuisance having
to post such long copy just
to match all
the bl--- lies innit.
FOR IMMEDIATE RELEASE
Crisis in
the National Cancer Institute
CHICAGO, IL, May 3, 2010 --/WORLD-WIRE/-- Cancer Prevention Coalition Chairman Samuel S. Epstein, M.D. says avoidable causes of cancer are being ignored by U.S. federal agencies while nearly one in two men and more than one in three women in this country now develop cancer in their lifetimes.
He cites an April 25 New York Times editorial on
the National Academy of Sciences' new report that National Cancer Institute's (NCI) system for judging
the clinical effectiveness of cancer treatments
is approaching "a state of crisis."
As critical, says Dr. Epstein, "
the NCI's system for publicizing avoidable causes of cancer remains virtually non-existent, even though nearly one in two men and more than one in three women now develop cancer in their lifetimes."
On April 24, Nobel Laureate Dr. Francis Collins, director of
the National Institutes of Health (NIH), appointed by President Barack Obama on August 2009, delivered
the Francis Collins Lecture in Chicago. Dr. Collins' lecture focused on his landmark discoveries of
the genetic basis of disease, including cancer. In reference
to a question on
the role of genetics in avoidable causes of cancer, Dr. Collins responded, "I am unaware of any avoidable causes of cancer."
Dr. Epstein says it
is not surprising that President Obama still remains unaware of a wide range of avoidable causes of a wide range of cancers as summarized in
the following press release issued by
the Cancer Prevention Coalition nearly 18 months ago.
January 23, 2009 --/WORLD-WIRE/-- President Barack Obama
is the first President
to develop a comprehensive cancer plan. While
the plan reflects strong emphasis on oncology,
the diagnosis and treatment of cancer, no reference
is made
to prevention.
President Obama's cancer plan should emphasize
the many avoidable causes of cancer.
The plan defines and coordinates
the responsibilities of four federal agencies:
the National Cancer Institute (NCI), for research and clinical trials;
the Centers for Disease Control and Prevention, for epidemiological follow up and support of cancer survivors;
the Centers for Medicare & Medicaid Services, for funding cancer related care; and
the FDA, for regulating cancer drugs.
In 1971, Congress passed
the National Cancer Act which authorized
the National Cancer Program, calling for an expanded and intensified research program for
the prevention of cancer caused by occupational or environmental exposures
to carcinogens. Shortly afterwards, President Richard Nixon announced his "War Against Cancer," and authorized a $200 million budget for
the NCI. Since then, its budget has escalated by nearly 30-fold,
to $5.3 billion this year.
Meanwhile,
the incidence of a wide range of cancers, other than those due
to smoking, has escalated sharply from 1975
to 2005, when
the latest NCI statistics were published. These include malignant melanoma (172%), Non-Hodgkin's lymphoma (79%), thyroid (116%), testes (60%), and childhood cancers (38%).
In November 2008,
the NCI claimed that
the incidence of new cancers had been falling from 1999
to 2005. However, this
is contrary
to its own latest statistics. These show increases of 45% for thyroid cancer, 18% for malignant melanoma, 18% for kidney cancer, 10% for childhood cancers, and 4% for testes cancer.
Disturbingly,
the NCI has still failed
to develop, let alone publicize, any listing or registry of avoidable exposures
to a wide range of carcinogens. These include: some pharmaceuticals; high dose diagnostic radiation; occupational; environmental; and ingredients in consumer products - food, household products, and cosmetics and personal care products.
The NCI has also failed
to respond, other than misleadingly or dismissively,
to prior Congressional requests for such information.
In March 1998, in a series of questions
to then NCI Director Dr. Richard Klausner, Congressman David Obey requested information on NCI's policies and priorities. He asked, "Should
the NCI develop a registry of avoidable carcinogens and make this information widely available
to the public?"
The answer was, and remains, no.
Klausner's responses made it clear that NCI persisted in indifference
to cancer prevention, coupled with imbalanced emphasis on damage control - screening, diagnosis, treatment, and clinical trials.
Moreover, NCI's claims for
the success of "innovative treatment" have been sharply criticized by distinguished oncologists. In 2004, Nobelist Leland Hartwell, President of
the Fred Hutchinson Cancer Control Center, warned that "Congress and
the public are not paying NCI $4.7 billion a year," most of which
is spent on "promoting ineffective drugs" for terminal disease.
It should be further emphasized that
the costs of new biotech cancer drugs have increased more than 100-fold over
the last decade. Furthermore,
the U.S. spends five times more than
the U.K. on chemotherapy per patient, although their survival rates are similar.
The Obama Cancer Plan
is subject
to Congressional authorization, and funding approval by
the House and Senate Appropriations Committees. These committees will be in a position
to require that major priority should be directed
to cancer prevention rather than
to oncology. Clearly,
the more cancer
is prevented,
the less there
is to treat. This will also be of major help in achieving Obama's goal "
to lower health care costs," said
the Cancer Prevention Coalition in
the above January 23, 2009 news release.
Today, Dr. Epstein says, "An encouraging move in support of directing priority
to prevention
is the April 2010 appointment of a 'National Cancer Advisory Board (NCAB) Ad Hoc Working Group'
to review NCI's opportunities for 'diagnosing, treating, and preventing cancer.'"
Samuel S. Epstein, M.D.
is professor emeritus of Environmental and Occupational Medicine at
the University of Illinois at Chicago School of Public Health; Chairman of
the Cancer Prevention Coalition;
The Albert Schweitzer Golden Grand Medalist for International Contributions
to Cancer Prevention; and author of over 200 scientific articles and 15 books on
the causes and prevention of cancer, including
the groundbreaking
The Politics of Cancer (1979), and Toxic Beauty (2009 Benbella Press).
To read Dr. Epstein's columns in
the Huffington Post,
go to:
http://www.huffingtonpost.com/samuel-s-epstein
CONTACT:
Samuel S. Epstein, M.D.
Chairman, Cancer Prevention Coalition
Professor emeritus Environmental & Occupational Medicine
University of Illinois at Chicago School of Public Health
Chicago, Illinois
Tel: 312-996-2297
Email:
epstein@uic.edu
www.preventcancer.com
The Cancer Prevention Coalition's January 23, 2009 news release reproduced above was endorsed by
the following 20 leading national experts in cancer prevention:
Nicholas A. Ashford, PhD, JD
Professor of Technology and Policy
Director, MIT Technology and Law Program
Massachusetts Institute of Technology
Cambridge, Massachusetts
Rosalie Bertell, PhD
International Association for Humanitarian Medicine
International Science Oversight Committee for
the Organic Consumers Association
Yardley, Pennsylvania
James Brophy, PhD
Adjunct Assistant Professor
Department of Sociology and Anthropology
Board of Directors, Toxic Free Canada
University of Windsor
Ontario, Canada
Richard Clapp, D.Sc., MPH
Professor
Boston University School of Public Health
Boston, Massachusetts
Paul Connett, PhD
Professor Emeritus of Environmental Chemistry,
St. Lawrence University
Canton, New York;
Executive Director
Fluoride Action Network
Canton, New York
Ronnie Cummins
National Director
Organic Consumers Association
Finland, Minnesota
Tracey Easthope, MPH
Director, Environmental Health Project
Ecology Center
Ann Arbor, Michigan
Lennart Hardell, MD, PhD
Professor
Department of Oncology
University Hospital
Orebro, Sweden
Hazel Henderson, D.Sc.Hon., FRSA
President, Ethical Markets Media, LLC;
Co-Creator,
the Calvert Group of
the Calvert-Henderson Quality of Life Indicators
Margaret Keith, PhD
Adjunct Assistant Professor
Department of Sociology and Anthropology
Board of Directors Toxic Free Canada
University of Windsor
Ontario, Canada
Joseph Mangano, MPH, MBA
Executive Director
Radiation and Public Health Project
New York, New York
James R. Mellow, MD, MS
Robert Wood Johnson Family Medicine Fellow
Physicians for Social Responsibility
Alliance for a Clean and Healthy Maine
Portland, Maine
Vicente Navarro, MD, PhD
Professor of Health Policy
The Johns Hopkins Medical Institutions
Baltimore, Maryland
Peter Orris, MD, MPH, FACP, FACOEM
Professor and Chief of Service
Environmental and Occupational Medicine
University of Illinois at Chicago Medical Center;
Professor, Internal and Preventive Medicine
Rush University College of Medicine;
Professor, Preventive Medicine
Northwestern University Feinberg School of Medicine
Chicago, Illinois
Lawrence A. Plumlee, MD
President, Chemical Sensitivity Disorders Association
Bethesda, Maryland
Horst Rechelbacher
President, Intelligent Nutrients
Minneapolis, Minnesota
Janette D. Sherman, MD
Adjunct Professor Environmental Institute
Western Michigan University
Kalamazoo, Michigan
Eileen M. Wright, MD, ABIHM
Great Smokies Medical Center
Asheville, North Carolina
Daphne Wysham
Fellow, Institute for Policy Studies
Washington, District of Columbia
Quentin D. Young, MD
Public Health Advocate, State of Illinois
Chairman, Health and Medicine Policy Research Group
Past President American Public Health Association
Chicago, Illinois